ロード中...
Novel Antibody for the Treatment of Transthyretin Amyloidosis
Familial amyloidotic polyneuropathy (FAP) is a systemic amyloidosis mainly caused by amyloidogenic transthyretin (ATTR). This incurable disease causes death ∼10 years after onset. Although it has been widely accepted that conformational change of the monomeric form of transthyretin (TTR) is very imp...
保存先:
| 出版年: | J Biol Chem |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Biochemistry and Molecular Biology
2016
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5122777/ https://ncbi.nlm.nih.gov/pubmed/27758856 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.M116.738138 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|